The PI3Kβ isoform is an important lipid kinase that regulates the PI3K signalling pathway and the survival of PTEN-deficient tumour cells, so PI3Kβ inhibitors have a role in PTEN-deficient cancers and are expected to improve clinical efficacy through drug combination.84 The gene discussed is PIK3CD; the disease is cancer.